Key Insights

Highlights

Treatment Research

2 treatments under study, led by Sotalol

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Unknown3

Clinical Trials (3)

Showing 3 of 3 trials
NCT06272357UnknownPrimary

The Use of Antiarrhythmic Drugs in Pediatrics

NCT05902676Unknown

The Effects Of Anticholinergic Burden On Daily Living Activities In Elderly Patients

NCT05418036Phase 4Unknown

Safety Assessment for Sotalol Protocol in Outpatient Unit

Showing all 3 trials

Research Network

Common Treatments

  • Sotalol1
  • Antiarrhythmic Drugs1

Active Sponsors

  • Assiut University1
  • Izmir Ataturk Training and Research Hospital1
  • University of Sao Paulo General Hospital1

Top Investigators

Related Conditions

  • Proarrhythmia1
  • Psychotropic Agents Causing Adverse Effects In Therapeutic Use1
  • Ventricular Arrythmia1
  • Anticholinergic Adverse Reaction1
  • Antiparkinsonism Drugs Causing Adverse Effects In Therapeutic Use1

Activity Timeline